Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia

European Journal of Pain (United Kingdom)

Volumn 17, Issue 4, 2013, Pages 581-586

  Wolfe, F ^a   Walitt, B T ^b   Katz, R S ^c   Lee, Y C ^d   Michaud, K D ^a   Hauser W ^e  

^a NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c RUSH UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; BUTORPHANOL; DEXTROPROPOXYPHENE; DULOXETINE; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; METHADONE; MILNACIPRAN; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; PREGABALIN; TRAMADOL;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG COST; DRUG USE; FATIGUE; FIBROMYALGIA; FUNCTIONAL STATUS; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PAIN; PAIN ASSESSMENT; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; VISUAL ANALOG SCALE;

ADULT; AGED; ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISABILITY EVALUATION; FEMALE; FIBROMYALGIA; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PAIN MEASUREMENT; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84879575387     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2012.00234.x     Document Type: Article

References (16)

1. Barker, K.K. (2011). Listening to Lyrica: Contested illnesses and pharmaceutical determinism. Soc Sci Med 73, 833-842.
2. Berger, A., Dukes, E., Martin, S., Edelsberg, J., Oster, G. (2007). Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 61, 1498-1508.
3. Breivik, H., Collett, B., Ventafridda, V., Cohen, R., Gallacher, D. (2006). Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 10, 287-333.
4. Briley, M. (2009). Drugs to treat fibromyalgia - the transatlantic difference. Curr Opin Investig Drugs 11, 16-18.
5. Chappell, A.S., Littlejohn, G., Kajdasz, D.K., Scheinberg, M., D'Souza, D.N., Moldofsky, H. (2009). A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia. Clin J Pain 25, 365-375.
6. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (Hillsdale: Lawrence Erlbaum).
7. Corporation, S. (2011). Stata Statistical Software: Release 12.0 (College Station, TX: Stata Corporation).
8. Hauser, W., Petzke, F., Sommer, C. (2010a). Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 11, 505-521.
9. Hauser, W., Thieme, K., Turk, D.C. (2010b). Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain 14, 5-10.
10. Häuser, W., Petzke, F., Üçeyler, N., Sommer, C. (2011). Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: A systematic review with meta-analysis. Rheumatology 50, 532.
11. Mease, P.J., Russell, I.J., Kajdasz, D.K., Wiltse, C.G., Detke, M.J., Wohlreich, M.M., Walker, D.J., Chappell, A.S. (2009). Longterm safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Semin Arthritis Rheum 39, 454-464.
12. Murphy, K., Zeiher, B., Herman, B., Atkinson, G., Pauer, L., Whelan, L. (2009). Long-term safety and tolerability of pregabalin treatment in three open-label extension studies in patients with fibromyalgia. J Pain 10, S58-S58.
13. Taylor, G., Wainwright, P. (2005). Open label extension studies: Research or marketing? BMJ 331, 572.
14. Wolfe, F., Hassett, A.F., Katz, R.S., Michaud, K. (2011). Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice. J Rheumatol 38, 1104-1112.
15. Wolfe, F., Michaud, K. (2010a). The Hawthorne effect, sponsored trials, and the overestimation of treatment effectiveness. J Rheumatol 37, 2216.
16. Wolfe, F., Michaud, K. (2010b). Themed issues 2010: The National Data Bank for Rheumatic Diseases (NDB): A multiregistry rheumatic disease data bank. Rheumatology (Oxford) 50, 16-24.